ArticleNature communications2019
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors.
Timo Reisländer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
134 papers cite itlatest 60 shown
this paperpooled ittrialcites it